Medicine
Byetta 300 mcg/1.2 mL injection
Byetta 300 mcg/1.2 mL injection is a prescription medicine containing Exenatide for subcutaneous use, marketed by AstraZeneca Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store BYETTA in the refrigerator at 36°F to 46°F (2°C to 8°C). • After first…
Key facts
- Active ingredient (INN)
- Exenatide
- Brand
- Byetta
- Strength
- 300 mcg/1.2 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 cartridge of 1.2 mL
- Marketing authorisation holder
- AstraZeneca Pharmaceuticals
- Manufacturer
- AstraZeneca Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store BYETTA in the refrigerator at 36°F to 46°F (2°C to 8°C). • After first use, BYETTA can be kept at a temperature not to exceed 77°F (25°C). • Do not freeze.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BJ01 Exenatide
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 December 2014
- Identifiers
- RxCUI 847910, 847913, 847915 +1DailyMed set ID 53d03c03-ebf7-418d-88a8-533eabd2ee4fNDC 0310-6512Application NDA021773
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 cartridge in 1 carton / 1.2 mL in 1 cartridge | 0310-6512-01 | AstraZeneca Pharmaceuticals | 10 December 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Exenatide 300 mcg/1.2 mL injection.
Other strengths and forms of Exenatide
Clinical summary
Exenatide is a GLP-1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus, among other approved uses. It is available as injection for subcutaneous use. MedsAcross supplies Exenatide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ExenatideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Byetta prescribing information (AstraZeneca Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Byetta 300 mcg/1.2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.